Targeted degradation via direct 26S proteasome recruitment

被引:0
作者
Charlene Bashore
Sumit Prakash
Matthew C. Johnson
Ryan J. Conrad
Ivy A. Kekessie
Suzie J. Scales
Noriko Ishisoko
Tracy Kleinheinz
Peter S. Liu
Nataliya Popovych
Aaron T. Wecksler
Lijuan Zhou
Christine Tam
Inna Zilberleyb
Rajini Srinivasan
Robert A. Blake
Aimin Song
Steven T. Staben
Yingnan Zhang
David Arnott
Wayne J. Fairbrother
Scott A. Foster
Ingrid E. Wertz
Claudio Ciferri
Erin C. Dueber
机构
[1] Genentech Inc.,Department of Early Discovery Biochemistry
[2] Genentech Inc.,Department of Discovery Oncology
[3] Genentech Inc.,Department of Structural Biology
[4] Genentech Inc.,Department of Immunology
[5] Genentech Inc.,Department of Biochemical and Cellular Pharmacology
[6] Genentech Inc.,Department of Microchemistry, Proteomics, and Lipidomics
[7] Genentech Inc.,Department of Protein Analytical Chemistry
[8] Genentech Inc.,Department of Biomolecular Resources
[9] Genentech Inc.,Department of Molecular Biology
[10] Genentech Inc.,Department of Discovery Chemistry
来源
Nature Chemical Biology | 2023年 / 19卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Engineered destruction of target proteins by recruitment to the cell’s degradation machinery has emerged as a promising strategy in drug discovery. The majority of molecules that facilitate targeted degradation do so via a select number of ubiquitin ligases, restricting this therapeutic approach to tissue types that express the requisite ligase. Here, we describe a new strategy of targeted protein degradation through direct substrate recruitment to the 26S proteasome. The proteolytic complex is essential and abundantly expressed in all cells; however, proteasomal ligands remain scarce. We identify potent peptidic macrocycles that bind directly to the 26S proteasome subunit PSMD2, with a 2.5-Å-resolution cryo-electron microscopy complex structure revealing a binding site near the 26S pore. Conjugation of this macrocycle to a potent BRD4 ligand enabled generation of chimeric molecules that effectively degrade BRD4 in cells, thus demonstrating that degradation via direct proteasomal recruitment is a viable strategy for targeted protein degradation.
引用
收藏
页码:55 / 63
页数:8
相关论文
共 121 条
[1]  
Schwartz AL(2008)Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology Annu. Rev. Pharm. 49 73-96
[2]  
Ciechanover A(2019)Development of targeted protein degradation therapeutics Nat. Chem. Biol. 15 937-944
[3]  
Chamberlain PP(2020)Proteolysis-targeting chimeras as therapeutics and tools for biological discovery Cell 181 102-114
[4]  
Hamann LG(2021)Targeted protein degraders crowd into the clinic Nat. Rev. Drug Discov. 20 247-250
[5]  
Burslem GM(2012)Targeting the von Hippel–Lindau E3 ubiquitin ligase using small molecules to disrupt the VHL/HIF-1α interaction J. Am. Chem. Soc. 134 4465-4468
[6]  
Crews CM(2015)Phthalimide conjugation as a strategy for in vivo target protein degradation Science 348 1376-1381
[7]  
Mullard A(2015)Catalytic in vivo protein knockdown by small-molecule PROTACs Nat. Chem. Biol. 11 611-617
[8]  
Buckley DL(2016)PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer Proc. Natl Acad. Sci. USA 113 7124-7129
[9]  
Winter GE(2015)Selective small molecule induced degradation of the BET bromodomain protein BRD4 ACS Chem. Biol. 10 1770-1777
[10]  
Bondeson DP(2001)PROTACs: chimeric molecules that target proteins to the Skp1–Cullin–F box complex for ubiquitination and degradation Proc. Natl Acad. Sci. USA 98 8554-8559